Jiang Mingyue, Chen Le, Chen Bo, Yu Qinghua, Zhang Xianming, Jing Weihong, Ma Limei, Deng Tao, Yang Zhangyou, Yu Chao
Chongqing Key Laboratory for Pharmaceutical Metabolism Research, College of Pharmacy, Chongqing Medical University, Chongqing, China.
Research Center of Pharmaceutical Preparations and Nanomedicine, College of Pharmacy, Chongqing Medical University, Chongqing, China.
Front Bioeng Biotechnol. 2022 Jun 30;10:919189. doi: 10.3389/fbioe.2022.919189. eCollection 2022.
Curcumin (CUR) is a natural bioactive compound that has attracted attention as a "golden molecule" due to its therapeutic properties against several types of tumors. Nonetheless, the antitumor application of CUR is hampered due to its extremely low aqueous solubility and chemical instability. Herein, a novel type of CUR-loaded polymeric micelles with intracellular K-responsive controlled-release properties is designed and developed. The polymeric micelles are self-assembled by poly (-isopropylacrylamide--acryloylamidobenzo-15-crown-5--, -dimethylacrylamide)-b-DSPE (PNDB-b-DSPE) block copolymers, and CUR. CUR is successfully loaded into the micelles with a CUR loading content of 6.26 wt%. The proposed CUR-PNDB-DSPE polymeric micelles exhibit a significant CUR release in simulated intracellular fluid due to the formation of 2 : 1 ''sandwich'' host-guest complexes of 15-crown-5 and K, which lead to the hydrophilic outer shell of micelles to collapse and the drug to rapidly migrate out of the micelles. , the B16F10 cell experiment indicates that CUR-PNDB-DSPE micelles exhibit a high cellular uptake and excellent intracellular drug release in response to the intracellular K concentration. Moreover, CUR-PNDB-DSPE micelles show high cytotoxicity to B16F10 cells compared to free CUR and CUR-PEG-DSPE micelles. The polymeric micelles with intracellular K-responsive controlled release properties proposed in this study provide a new strategy for designing novel targeted drug delivery systems for CUR delivery for cancer treatment.
姜黄素(CUR)是一种天然生物活性化合物,因其对多种类型肿瘤的治疗特性而作为“黄金分子”受到关注。然而,CUR的抗肿瘤应用因其极低的水溶性和化学不稳定性而受到阻碍。在此,设计并开发了一种新型的具有细胞内钾离子响应控释特性的负载CUR的聚合物胶束。该聚合物胶束由聚(-异丙基丙烯酰胺--丙烯酰氨基苯并-15-冠-5--,-二甲基丙烯酰胺)-b-二硬脂酰基磷脂酰乙醇胺(PNDB-b-DSPE)嵌段共聚物和CUR自组装而成。CUR成功负载到胶束中,CUR负载量为6.26 wt%。所提出的CUR-PNDB-DSPE聚合物胶束在模拟细胞内液中表现出显著的CUR释放,这是由于15-冠-5与钾形成2:1的“三明治”主客体复合物,导致胶束的亲水外壳坍塌,药物迅速从胶束中迁移出来。此外,B16F10细胞实验表明,CUR-PNDB-DSPE胶束在细胞内钾离子浓度的响应下表现出高细胞摄取率和优异的细胞内药物释放。而且,与游离CUR和CUR-PEG-DSPE胶束相比,CUR-PNDB-DSPE胶束对B16F10细胞显示出高细胞毒性。本研究中提出的具有细胞内钾离子响应控释特性的聚合物胶束为设计用于癌症治疗的CUR递送的新型靶向药物递送系统提供了一种新策略。